March 12, 2020Diffusion Pharmaceuticals Inc. • March 18th, 2020 • Pharmaceutical preparations • Virginia
In a communication dated February 2, 2020, you announced to the Board of Directors of Diffusion Pharmaceuticals Inc. ("Board") your intent to retire from Diffusion Pharmaceuticals Inc. ("Company"). The Company has accepted your retirement. This letter termination agreement and general release ("Agreement") will confirm the separation from employment of Dr. John L. Gainer ("you" or "your") from the Company, under the following terms and conditions:
Consulting AgreementConsulting Agreement • March 18th, 2020 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations • Virginia
This Agreement is made between Diffusion Pharmaceuticals Inc. ("Diffusion" or "Client"), with a principal place of business at 1317 Carlton Avenue, Charlottesville, Virginia 22902, and John L. Gainer, PhD ("Consultant"), with a residence at 125 Cameron Lane, Charlottesville, VA 22903. This Agreement became effective as of March 12, 2020, and will end on March 11, 2021, unless renewed in writing by all parties hereto or terminated earlier in accordance with this Agreement.
